Literature DB >> 195979

Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans.

B D Baxter, R B Couch, S B Greenberg, J A Kasel.   

Abstract

A comparison of Hanks balanced salt solution, veal infusion broth (VIB), and charcoal viral transport medium for maintaining viability of type A influenza virus indicated approximately equal survival of virus on all three media at -70 and 4 degrees C, whereas at 25 degrees C virus survived best in VIB. VIB supplemented with bovine serum albumin was used as transport medium in a community-wide surveillance of febrile respiratory disease for influenza viruses. Unfrozen throat swab specimens were placed in VIB and stored at 4 degrees C for up to 5 days without effect on isolation frequencies of either type A or type B influenza virus or type 1 or type 3 parainfluenza virus. Comparison of indirect immunofluorescence with hemadsorption for detection of type A influenza virus in rhesus monkey kidney cultures revealed a requirement for at least five fluorescing cells to eliminate false positive indirect immunofluorescence tests and at least 3 days of incubation to eliminate false negative tests when compared with hemadsorption at later times. Detection frequencies for the two methods after 2 and 3 days of incubation were not significantly different.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195979      PMCID: PMC274690          DOI: 10.1128/jcm.6.1.19-22.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Hemadsorption (adsorption-hemagglutination) test for viral agents in tissue culture with special reference to influenza.

Authors:  A SHELOKOV; J E VOGEL; L CHI
Journal:  Proc Soc Exp Biol Med       Date:  1958-04

2.  Immunofluorescent diagnosis of acute viral infection.

Authors:  V Knight; F Brasier; S B Greenberg; D B Jones
Journal:  South Med J       Date:  1975-06       Impact factor: 0.954

3.  A simple scheme for the early detection of influenza virus type A.

Authors:  J Hockney; L Bellenger; I A Harper
Journal:  Med Lab Technol       Date:  1974-01

4.  Rapid identification of viruses by indirect immunofluorescence: standardization and use of antiserum pool to nine respiratory viruses.

Authors:  T D Stevens; H M Watkins
Journal:  Appl Microbiol       Date:  1969-03

5.  Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.

Authors:  R B Couch; R G Douglas; D S Fedson; J A Kasel
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

6.  Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; J Kasel; R M Chanock
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

  6 in total
  18 in total

1.  Safety and pharmacokinetics of rimantadine small-particle aerosol.

Authors:  R L Atmar; S B Greenberg; J M Quarles; S Z Wilson; B Tyler; S Feldman; R B Couch
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons.

Authors:  H R Six; R G Webster; A P Kendal; W P Glezen; C Griffis; R B Couch
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

3.  Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains.

Authors:  J G Velazco; R B Couch; H R Six; W P Glezen
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

4.  Enzyme immunoassay for direct detection of influenza type A and adenovirus antigens in clinical specimens.

Authors:  M W Harmon; K M Pawlik
Journal:  J Clin Microbiol       Date:  1982-01       Impact factor: 5.948

5.  Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine.

Authors:  S W Younkin; R F Betts; F K Roth; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

6.  Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.

Authors:  S Z Wilson; B E Gilbert; J M Quarles; V Knight; H W McClung; R V Moore; R B Couch
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

7.  Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes.

Authors:  Lauren P McLaughlin; Haili Lang; Elizabeth Williams; Kaylor E Wright; Allison Powell; Conrad R Cruz; Anamaris M Colberg-Poley; Cecilia Barese; Patrick J Hanley; Catherine M Bollard; Michael D Keller
Journal:  Cytotherapy       Date:  2016-09-28       Impact factor: 5.414

8.  Effects of social and family factors on viral respiratory infection and illness in the first year of life.

Authors:  G Gardner; A L Frank; L H Taber
Journal:  J Epidemiol Community Health       Date:  1984-03       Impact factor: 3.710

9.  Serum neutralizing antibody and lymphocyte transformation responses after influenza B virus infections.

Authors:  J M Zahradnik; A L Frank; L H Taber
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.

Authors:  J A Englund; P A Piedra; A Jewell; K Patel; B B Baxter; E Whimbey
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.